Synopsis of recent research by authors named "Fakhara Sabir"
- Fakhara Sabir's recent research primarily focuses on the development and optimization of innovative drug delivery systems, especially targeting glioblastoma multiforme and other cancers using various nanocarrier technologies, including liposomes, microemulsions, and nanoparticles.
- A notable finding from Sabir's studies is the effective utilization of intranasal administration and pH-sensitive formulations, which enhance drug bioavailability and mitigate adverse effects typically associated with systemic chemotherapy, thus improving therapeutic outcomes.
- Additionally, Sabir's work emphasizes the incorporation of natural compounds and responsive materials, such as -propyl gallate and lignin, into drug delivery systems to achieve targeted and efficient anti-cancer therapies while maintaining biocompatibility and low toxicity.